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The vector-borne diseases Lyme disease,
human babesiosis, and human granulocytic
ehrlichiosis (HGE) are emerging in the Northeast
and upper Midwest regions of the United States
(1,2). The etiologic agents for these diseases
(Borrelia burgdorferi, Babesia microti, and the
HGE agent, respectively) appear to share the
same vertebrate reservoir host (Peromyscus
leucopus) and tick vector (Ixodes scapularis) (3-6).
Immunologic evidence of human coinfection
with these pathogens has been reported (7-10),
and a culture-confirmed case of coinfection with
B. burgdorferi and the HGE agent has recently
been described (11). Thus, in Lyme disease–
endemic areas, there may be a substantial risk
for coinfection with B. burgdorferi and either B.
microti or the HGE-causing rickettsia.
Hunterdon County (population 118,000) is a
rural, but rapidly developing, county in western
New Jersey (Figure), with many homes in wooded
settings. In 1996, the county had the third highest
case rate of Lyme disease (524 per 100,000) of all
counties in the United States (Centers for Disease
Control and Prevention case reports). The county
has also had many suspected, but no serologically
confirmed, cases of HGE.
The risk of acquiring a tick-borne pathogen in
a specific geographic location depends largely on
tick density and the prevalence rate of the agent
in the tick population. Although cultivation of a
microbial agent is considered optimal, molecular
detection is more practical since it permits the
rapid assay of large numbers of individual
specimens. We report here the prevalence rate of
B. burgdorferi, B. microti, and the agent of HGE
in I. scapularis in Hunterdon County by species-
specific polymerase chain reaction (PCR).
One hundred adult I. scapularis were
collected by drag cloth or from personal clothing
at 10 sites in the county during the fall of 1996
(Figure). Ticks were stored at room temperature
in 70% ethanol until analysis. DNA was isolated
from individual ticks with the Isoquick DNA
extraction kit (ORCA Research, Bothell, WA)
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To assess the potential risk for other tick-borne diseases, we collected 100
adult Ixodes scapularis in Hunterdon County, a rapidly developing rural county in
Lyme disease–endemic western New Jersey. We tested the ticks by polymerase
chain reaction for Borrelia burgdorferi, Babesia microti, and the rickettsial agent of
human granulocytic ehrlichiosis (HGE). Fifty-five ticks were infected with at least
one of the three pathogens: 43 with B. burgdorferi, five with B. microti, and 17 with
the HGE agent. Ten ticks were coinfected with two of the pathogens. The results
suggest that county residents are at considerable risk for infection by a tick-borne
pathogen after an I. scapularis bite.
Figure. Map of New Jersey showing Hunterdon
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(12). The final DNA pellets were resuspended in
50  ml of sterile water, and a 10-ml aliquot was
used for each PCR test. B. burgdorferi–specific
PCR used primers IS1 and IS2 (13). The HGE
agent was detected by PCR using primers GER3
and GER4, as described by Munderloh et al. (14),
and  B. microti DNA was detected according to
methods used by Persing et al. (15). PCR products
were electrophoresed on 2% agarose gels stained
with ethidium bromide. For B. burgdorferi and B.
microti, hybridization with specific probes was
carried out after transfer to nylon membranes
(13). In each PCR experiment appropriate
negative controls were used; these included
master mix controls lacking template and
reactions containing B. burgdorferi DNA, HGE
agent DNA, or Escherichia coli DNA as additional
controls for HGE agent, B. burgdorferi, or B. microti
PCR, respectively. To prevent cross-contamina-
tion, specimen preparation, PCR amplification,
and post-PCR analysis were performed in
separate laboratories.
Results of PCR analysis for each of the
pathogens on individual ticks are presented in
the Table. At least one of the three pathogens was
present in 55% of the ticks. The highest
prevalence rate was that for B. burgdorferi (43/
100), followed by the agent of HGE (17/100) and
B. microti (5/100). Furthermore, these pathogens
were widely distributed. At least one tick at each
site was infected with B. burgdorferi, nine of 10
sites had HGE agent–positive ticks, and B.
microti–positive ticks were found at five
different collection sites. Ten ticks were
coinfected with two of the three agents; no ticks
were infected with all three pathogens. The B.
microti PCR amplification products were gel
purified and subjected to automated DNA
sequencing. The 238 bp products yielded
sequences identical to that reported for B.
microti 18S ribosomal DNA (15).
The prevalence rates for the three pathogens
reported here are consistent with earlier studies
at selected sites in the northeastern United
States. Telford et al. reported prevalence rates of
36%, 11%, and 9% for B. burgdorferi, the HGE
agent, and B. microti, respectively, in adult I.
scapularis on Nantucket Island, Massachusetts;
coprevalence of B. burgdorferi and the HGE
agent was 4%, and no simultaneous infection
with  B. burgdorferi and B. microti was observed
(4). We have reported prevalence rates of 52%
and 53% for B. burgdorferi and the HGE
pathogen, and coprevalence of 26% at a site in
Westchester County, New York (5). Given the
simultaneous infection of I. scapularis with these
pathogens, it is not surprising that numerous
serosurveys of Lyme disease patients indicate the
coincident presence of antibodies to B. burgdorferi
and B. microti and human granulocytic ehrlichia
(7-10). These findings do not establish concur-
rent, active infection, nor do they demonstrate
simultaneous transmission by a single tick bite;
however, they suggest that persons living in
disease-endemic areas are exposed to these
agents, presumably as a result of tick bites.
Human infection by any of the three tick-
borne agents alone generally results in similar
acute manifestations, including fever, headache,
and myalgia (1,10,16). Reported cases of Lyme
disease greatly outnumber those of babesiosis or
HGE. This, in conjunction with seroepidemiologic
data, suggests that many infections with B. microti
and granulocytic ehrlichia are subclinical. Dual
infection with B. burgdorferi and B. microti often
results in more severe illness (10); whether this is
also true for concurrent infection by the agents of
Lyme disease and HGE remains to be established.
Human coinfection by multiple tick-borne agents
may account for the variable nature of the clinical
manifestations of Lyme disease.
This study demonstrates that the agents of
Lyme disease, human babesiosis, and HGE
coexist in the tick population of a previously
identified Lyme disease–endemic region of New
Jersey. The study provides further evidence that
these three pathogens may be prevalent
throughout the range of I. scapularis. Infection
with any of these three tick-borne pathogens
should be considered for residents or visitors of a
disease-endemic area who have flulike symptoms
and a history of a tick bite.
Table. Prevalence rate of Borrelia burgdorferi, human
granulocytic ehrlichiosis (HGE) agent, and Babesia
microti in 100 adult  Ixodes scapularis
Pathogen No. infected ticks
B. burgdorferi 43
HGE agent 17
B. microti   5
B. burgdorferi and HGE agent   6
B. burgdorferi and B. microti   2
HGE agent and B. microti   2
B. burgdorferi, HGE agent,
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